JENNIFER G DAVILA

Allopathic & Osteopathic Physicians|Pediatrics|Pediatric Hematology-Oncology BRONX, NY NPI 1417265331

General Payments — all program years on this page

$90,308.79

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 90
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $41,545.76 across 33 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

By paying entity

Latest program year (PY2024) · sorted by reported total.

Paying entityAmountRecords
GENZYME CORPORATION $14,437.7410
Octapharma USA, Inc. $10,454.766
BioMarin Pharmaceutical Inc. $10,182.5710
Genentech USA, Inc. $6,470.697

By program year

Program yearAmountRecords
2018 $27.432
2019 $4,469.628
2020 $2,000.001
2021 $7,966.837
2022 $13,787.0520
2023 $20,512.1019
2024 $41,545.7633

Records — PY2024 (33)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1127057523 BioMarin Pharmaceutical Inc. $1,207.88 09/17/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1127059509 BioMarin Pharmaceutical Inc. $3,910.00 09/07/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 View at CMS
1127059519 BioMarin Pharmaceutical Inc. $91.67 09/07/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1127059543 BioMarin Pharmaceutical Inc. $268.95 09/07/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1127059557 BioMarin Pharmaceutical Inc. $303.97 09/07/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1127059565 BioMarin Pharmaceutical Inc. $171.47 09/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1127059579 BioMarin Pharmaceutical Inc. $107.23 09/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1127059593 BioMarin Pharmaceutical Inc. $124.79 09/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1127059607 BioMarin Pharmaceutical Inc. $86.61 09/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1127063062 BioMarin Pharmaceutical Inc. $3,910.00 10/25/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 View at CMS
1133030607 Genentech USA, Inc. $148.08 10/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1133030611 Genentech USA, Inc. $120.00 10/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1133030614 Genentech USA, Inc. $5,310.00 10/25/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1133030619 Genentech USA, Inc. $577.26 10/25/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1133030622 Genentech USA, Inc. $86.19 10/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1133030627 Genentech USA, Inc. $110.77 10/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1133030631 Genentech USA, Inc. $118.39 12/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139580238 GENZYME CORPORATION $608.55 06/01/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1139580240 GENZYME CORPORATION $380.31 06/01/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1139580242 GENZYME CORPORATION $341.33 06/01/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1139580244 GENZYME CORPORATION $164.01 06/01/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139580246 GENZYME CORPORATION $60.84 06/01/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139580248 GENZYME CORPORATION $70.00 06/01/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139580250 GENZYME CORPORATION $83.88 06/01/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139580252 GENZYME CORPORATION $12,465.00 06/01/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1139580254 GENZYME CORPORATION $132.39 06/01/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1139580264 GENZYME CORPORATION $131.43 09/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1142313656 Octapharma USA, Inc. $7,712.00 09/28/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1142313658 Octapharma USA, Inc. $256.14 09/28/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1142313660 Octapharma USA, Inc. $2,400.00 10/18/2024 Honoraria Undisputed 01/23/2026 View at CMS
1142313662 Octapharma USA, Inc. $7.00 10/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1142313664 Octapharma USA, Inc. $17.00 10/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1142313666 Octapharma USA, Inc. $62.62 10/18/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.